Global Osteoarthritis Pain Drugs Market Growth 2021-2026

  • receipt Report ID : 158484
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 176
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Osteoarthritis Pain Drugs will have significant change from previous year. By the most conservative estimates of global Osteoarthritis Pain Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 8115 million in 2019. Over the next five years the Osteoarthritis Pain Drugs market will register a 5.9% CAGR in terms of revenue, the global market size will reach US$ 10220 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Pain Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Oral

Injection

External

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Medical Care

Personal Care

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Sino Biopharmaceutical

Chugai Pharmaceutical

Pfizer

Mikasa Seiyaku

Bayer

Haohai Biological

SK Chemicals

Taisho Pharmaceutical

Zhejiang Chengyi Pharmaceutical

Freda

Bright Future

Jingfeng Pharmaceutical

Seikagaku Corporation

GSK

Sanofi

Crystal Genomics

Johnson & Johnson

GlaxoSmithKline

Mylan

Lilly

Abbott Laboratories

Almatica Pharma

TEVA

Iroko Pharmaceuticals

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Osteoarthritis Pain Drugs Consumption 2016-2026

2.1.2 Osteoarthritis Pain Drugs Consumption CAGR by Region

2.2 Osteoarthritis Pain Drugs Segment by Type

2.2.1 Oral

2.2.2 Injection

2.2.3 External

2.3 Osteoarthritis Pain Drugs Sales by Type

2.3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)

2.3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2016-2021)

2.3.3 Global Osteoarthritis Pain Drugs Sale Price by Type (2016-2021)

2.4 Osteoarthritis Pain Drugs Segment by Application

2.4.1 Medical Care

2.4.2 Personal Care

2.5 Osteoarthritis Pain Drugs Sales by Application

2.5.1 Global Osteoarthritis Pain Drugs Sale Market Share by Application (2016-2021)

2.5.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Application (2016-2021)

2.5.3 Global Osteoarthritis Pain Drugs Sale Price by Application (2016-2021)

3 Global Osteoarthritis Pain Drugs by Company

3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Company

3.1.1 Global Osteoarthritis Pain Drugs Sales by Company (2019-2021)

3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Company (2019-2021)

3.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company

3.2.1 Global Osteoarthritis Pain Drugs Revenue by Company (2019-2021)

3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2019-2021)

3.3 Global Osteoarthritis Pain Drugs Sale Price by Company

3.4 Global Manufacturers Osteoarthritis Pain Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Osteoarthritis Pain Drugs Product Location Distribution

3.4.2 Players Osteoarthritis Pain Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Osteoarthritis Pain Drugs by Region

4.1 Global Osteoarthritis Pain Drugs by Region

4.1.1 Global Osteoarthritis Pain Drugs Sales by Region

4.1.2 Global Osteoarthritis Pain Drugs Revenue by Region

4.2 Americas Osteoarthritis Pain Drugs Sales Growth

4.3 APAC Osteoarthritis Pain Drugs Sales Growth

4.4 Europe Osteoarthritis Pain Drugs Sales Growth

4.5 Middle East & Africa Osteoarthritis Pain Drugs Sales Growth

5 Americas

5.1 Americas Osteoarthritis Pain Drugs Sales by Country

5.1.1 Americas Osteoarthritis Pain Drugs Sales by Country (2016-2021)

5.1.2 Americas Osteoarthritis Pain Drugs Revenue by Country (2016-2021)

5.2 Americas Osteoarthritis Pain Drugs Sales by Type

5.3 Americas Osteoarthritis Pain Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Osteoarthritis Pain Drugs Sales by Region

6.1.1 APAC Osteoarthritis Pain Drugs Sales by Region (2016-2021)

6.1.2 APAC Osteoarthritis Pain Drugs Revenue by Region (2016-2021)

6.2 APAC Osteoarthritis Pain Drugs Sales by Type

6.3 APAC Osteoarthritis Pain Drugs Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Osteoarthritis Pain Drugs by Country

7.1.1 Europe Osteoarthritis Pain Drugs Sales by Country (2016-2021)

7.1.2 Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2021)

7.2 Europe Osteoarthritis Pain Drugs Sales by Type

7.3 Europe Osteoarthritis Pain Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Osteoarthritis Pain Drugs by Country

8.1.1 Middle East & Africa Osteoarthritis Pain Drugs Sales by Country (2016-2021)

8.1.2 Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2021)

8.2 Middle East & Africa Osteoarthritis Pain Drugs Sales by Type

8.3 Middle East & Africa Osteoarthritis Pain Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Osteoarthritis Pain Drugs Distributors

10.3 Osteoarthritis Pain Drugs Customer

11 Global Osteoarthritis Pain Drugs Market Forecast

11.1 Global Osteoarthritis Pain Drugs Forecast by Region

11.1.1 Global Osteoarthritis Pain Drugs Forecast by Regions (2021-2026)

11.2.2 Global Osteoarthritis Pain Drugs Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Osteoarthritis Pain Drugs Forecast by Type

11.7 Global Osteoarthritis Pain Drugs Forecast by Application

12 Key Players Analysis

12.1 Sino Biopharmaceutical

12.1.1 Sino Biopharmaceutical Sino Biopharmaceutical Company Information

12.1.2 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Offered

12.1.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sino Biopharmaceutical Main Business Overview

12.1.5 Sino Biopharmaceutical Latest Developments

12.2 Chugai Pharmaceutical

12.2.1 Chugai Pharmaceutical Company Information

12.2.2 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Offered

12.2.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Chugai Pharmaceutical Main Business Overview

12.2.5 Chugai Pharmaceutical Latest Developments

12.3 Pfizer

12.3.1 Pfizer Company Information

12.3.2 Pfizer Osteoarthritis Pain Drugs Product Offered

12.3.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Pfizer Main Business Overview

12.3.5 Pfizer Latest Developments

12.4 Mikasa Seiyaku

12.4.1 Mikasa Seiyaku Company Information

12.4.2 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Offered

12.4.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Mikasa Seiyaku Main Business Overview

12.4.5 Mikasa Seiyaku Latest Developments

12.5 Bayer

12.5.1 Bayer Company Information

12.5.2 Bayer Osteoarthritis Pain Drugs Product Offered

12.5.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Bayer Main Business Overview

12.5.5 Bayer Latest Developments

12.6 Haohai Biological

12.6.1 Haohai Biological Company Information

12.6.2 Haohai Biological Osteoarthritis Pain Drugs Product Offered

12.6.3 Haohai Biological Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Haohai Biological Main Business Overview

12.6.5 Haohai Biological Latest Developments

12.7 SK Chemicals

12.7.1 SK Chemicals Company Information

12.7.2 SK Chemicals Osteoarthritis Pain Drugs Product Offered

12.7.3 SK Chemicals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 SK Chemicals Main Business Overview

12.7.5 SK Chemicals Latest Developments

12.8 Taisho Pharmaceutical

12.8.1 Taisho Pharmaceutical Company Information

12.8.2 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Offered

12.8.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Taisho Pharmaceutical Main Business Overview

12.8.5 Taisho Pharmaceutical Latest Developments

12.9 Zhejiang Chengyi Pharmaceutical

12.9.1 Zhejiang Chengyi Pharmaceutical Company Information

12.9.2 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Offered

12.9.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Zhejiang Chengyi Pharmaceutical Main Business Overview

12.9.5 Zhejiang Chengyi Pharmaceutical Latest Developments

12.10 Freda

12.10.1 Freda Company Information

12.10.2 Freda Osteoarthritis Pain Drugs Product Offered

12.10.3 Freda Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Freda Main Business Overview

12.10.5 Freda Latest Developments

12.11 Bright Future

12.11.1 Bright Future Company Information

12.11.2 Bright Future Osteoarthritis Pain Drugs Product Offered

12.11.3 Bright Future Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Bright Future Main Business Overview

12.11.5 Bright Future Latest Developments

12.12 Jingfeng Pharmaceutical

12.12.1 Jingfeng Pharmaceutical Company Information

12.12.2 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Offered

12.12.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Jingfeng Pharmaceutical Main Business Overview

12.12.5 Jingfeng Pharmaceutical Latest Developments

12.13 Seikagaku Corporation

12.13.1 Seikagaku Corporation Company Information

12.13.2 Seikagaku Corporation Osteoarthritis Pain Drugs Product Offered

12.13.3 Seikagaku Corporation Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Seikagaku Corporation Main Business Overview

12.13.5 Seikagaku Corporation Latest Developments

12.14 GSK

12.14.1 GSK Company Information

12.14.2 GSK Osteoarthritis Pain Drugs Product Offered

12.14.3 GSK Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 GSK Main Business Overview

12.14.5 GSK Latest Developments

12.15 Sanofi

12.15.1 Sanofi Company Information

12.15.2 Sanofi Osteoarthritis Pain Drugs Product Offered

12.15.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Sanofi Main Business Overview

12.15.5 Sanofi Latest Developments

12.16 Crystal Genomics

12.16.1 Crystal Genomics Company Information

12.16.2 Crystal Genomics Osteoarthritis Pain Drugs Product Offered

12.16.3 Crystal Genomics Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Crystal Genomics Main Business Overview

12.16.5 Crystal Genomics Latest Developments

12.17 Johnson & Johnson

12.17.1 Johnson & Johnson Company Information

12.17.2 Johnson & Johnson Osteoarthritis Pain Drugs Product Offered

12.17.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Johnson & Johnson Main Business Overview

12.17.5 Johnson & Johnson Latest Developments

12.18 GlaxoSmithKline

12.18.1 GlaxoSmithKline Company Information

12.18.2 GlaxoSmithKline Osteoarthritis Pain Drugs Product Offered

12.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 GlaxoSmithKline Main Business Overview

12.18.5 GlaxoSmithKline Latest Developments

12.19 Mylan

12.19.1 Mylan Company Information

12.19.2 Mylan Osteoarthritis Pain Drugs Product Offered

12.19.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Mylan Main Business Overview

12.19.5 Mylan Latest Developments

12.20 Lilly

12.20.1 Lilly Company Information

12.20.2 Lilly Osteoarthritis Pain Drugs Product Offered

12.20.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.20.4 Lilly Main Business Overview

12.20.5 Lilly Latest Developments

12.21 Abbott Laboratories

12.21.1 Abbott Laboratories Company Information

12.21.2 Abbott Laboratories Osteoarthritis Pain Drugs Product Offered

12.21.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.21.4 Abbott Laboratories Main Business Overview

12.21.5 Abbott Laboratories Latest Developments

12.22 Almatica Pharma

12.22.1 Almatica Pharma Company Information

12.22.2 Almatica Pharma Osteoarthritis Pain Drugs Product Offered

12.22.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.22.4 Almatica Pharma Main Business Overview

12.22.5 Almatica Pharma Latest Developments

12.23 TEVA

12.23.1 TEVA Company Information

12.23.2 TEVA Osteoarthritis Pain Drugs Product Offered

12.23.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.23.4 TEVA Main Business Overview

12.23.5 TEVA Latest Developments

12.24 Iroko Pharmaceuticals

12.24.1 Iroko Pharmaceuticals Company Information

12.24.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Offered

12.24.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.24.4 Iroko Pharmaceuticals Main Business Overview

12.24.5 Iroko Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Osteoarthritis Pain Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Oral

Table 3. Major Players of Injection

Table 4. Major Players of External

Table 5. Global Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)

Table 6. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)

Table 7. Global Osteoarthritis Pain Drugs Revenue by Type (2016-2021) & ($ million)

Table 8. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2021)

Table 9. Global Osteoarthritis Pain Drugs Sale Price by Type (2016-2021)

Table 10. Global Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)

Table 11. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)

Table 12. Global Osteoarthritis Pain Drugs Value by Application (2016-2021)

Table 13. Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2016-2021)

Table 14. Global Osteoarthritis Pain Drugs Sale Price by Application (2016-2021)

Table 15. Global Osteoarthritis Pain Drugs Sales by Company (2019-2021) & (M Dose)

Table 16. Global Osteoarthritis Pain Drugs Sales Market Share by Company (2019-2021)

Table 17. Global Osteoarthritis Pain Drugs Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Osteoarthritis Pain Drugs Revenue Market Share by Company (2019-2021)

Table 19. Global Osteoarthritis Pain Drugs Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Osteoarthritis Pain Drugs Producing Area Distribution and Sales Area

Table 21. Players Osteoarthritis Pain Drugs Products Offered

Table 22. Osteoarthritis Pain Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Osteoarthritis Pain Drugs Sales by Region (2016-2021) (M Dose)

Table 26. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)

Table 27. Global Osteoarthritis Pain Drugs Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2021)

Table 29. Americas Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)

Table 30. Americas Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)

Table 31. Americas Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)

Table 33. Americas Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)

Table 34. Americas Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)

Table 35. Americas Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)

Table 36. Americas Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)

Table 37. APAC Osteoarthritis Pain Drugs Sales by Region (2016-2021) & (M Dose)

Table 38. APAC Osteoarthritis Pain Drugs Sales Market Share by Region (2016-2021)

Table 39. APAC Osteoarthritis Pain Drugs Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Osteoarthritis Pain Drugs Revenue Market Share by Region (2016-2021)

Table 41. APAC Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)

Table 42. APAC Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)

Table 43. APAC Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)

Table 44. APAC Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)

Table 45. Europe Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)

Table 46. Europe Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)

Table 47. Europe Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)

Table 49. Europe Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)

Table 50. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)

Table 51. Europe Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)

Table 52. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Osteoarthritis Pain Drugs Sales by Country (2016-2021) & (M Dose)

Table 54. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Osteoarthritis Pain Drugs Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Osteoarthritis Pain Drugs Sales by Type (2016-2021) & (M Dose)

Table 58. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Osteoarthritis Pain Drugs Sales by Application (2016-2021) & (M Dose)

Table 60. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)

Table 61. Global Osteoarthritis Pain Drugs Sales Forecast by Type (2021-2026) & (M Dose)

Table 62. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Type (2021-2026)

Table 63. Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 64. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Type (2021-2026)

Table 65. Global Osteoarthritis Pain Drugs Sales Forecast by Application (2021-2026) & (M Dose)

Table 66. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Application (2021-2026)

Table 67. Global Osteoarthritis Pain Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 68. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Application (2021-2026)

Table 69. Sino Biopharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 70. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Offered

Table 71. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 72. Sino Biopharmaceutical Main Business

Table 73. Sino Biopharmaceutical Latest Developments

Table 74. Chugai Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 75. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Offered

Table 76. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 77. Chugai Pharmaceutical Main Business

Table 78. Chugai Pharmaceutical Latest Developments

Table 79. Pfizer Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 80. Pfizer Osteoarthritis Pain Drugs Product Offered

Table 81. Pfizer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 82. Pfizer Main Business

Table 83. Pfizer Latest Developments

Table 84. Mikasa Seiyaku Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 85. Mikasa Seiyaku Osteoarthritis Pain Drugs Product Offered

Table 86. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 87. Mikasa Seiyaku Main Business

Table 88. Mikasa Seiyaku Latest Developments

Table 89. Bayer Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 90. Bayer Osteoarthritis Pain Drugs Product Offered

Table 91. Bayer Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 92. Bayer Main Business

Table 93. Bayer Latest Developments

Table 94. Haohai Biological Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Haohai Biological Osteoarthritis Pain Drugs Product Offered

Table 96. Haohai Biological Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 97. Haohai Biological Main Business

Table 98. Haohai Biological Latest Developments

Table 99. SK Chemicals Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. SK Chemicals Osteoarthritis Pain Drugs Product Offered

Table 101. SK Chemicals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 102. SK Chemicals Main Business

Table 103. SK Chemicals Latest Developments

Table 104. Taisho Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Offered

Table 106. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 107. Taisho Pharmaceutical Main Business

Table 108. Taisho Pharmaceutical Latest Developments

Table 109. Zhejiang Chengyi Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Offered

Table 111. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 112. Zhejiang Chengyi Pharmaceutical Main Business

Table 113. Zhejiang Chengyi Pharmaceutical Latest Developments

Table 114. Freda Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Freda Osteoarthritis Pain Drugs Product Offered

Table 116. Freda Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 117. Freda Main Business

Table 118. Freda Latest Developments

Table 119. Bright Future Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Bright Future Osteoarthritis Pain Drugs Product Offered

Table 121. Bright Future Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 122. Bright Future Main Business

Table 123. Bright Future Latest Developments

Table 124. Jingfeng Pharmaceutical Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Offered

Table 126. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 127. Jingfeng Pharmaceutical Main Business

Table 128. Jingfeng Pharmaceutical Latest Developments

Table 129. Seikagaku Corporation Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Seikagaku Corporation Osteoarthritis Pain Drugs Product Offered

Table 131. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 132. Seikagaku Corporation Main Business

Table 133. Seikagaku Corporation Latest Developments

Table 134. GSK Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. GSK Osteoarthritis Pain Drugs Product Offered

Table 136. GSK Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 137. GSK Main Business

Table 138. GSK Latest Developments

Table 139. Sanofi Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Sanofi Osteoarthritis Pain Drugs Product Offered

Table 141. Sanofi Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 142. Sanofi Main Business

Table 143. Sanofi Latest Developments

Table 144. Crystal Genomics Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Crystal Genomics Osteoarthritis Pain Drugs Product Offered

Table 146. Crystal Genomics Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 147. Crystal Genomics Main Business

Table 148. Crystal Genomics Latest Developments

Table 149. Johnson & Johnson Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Johnson & Johnson Osteoarthritis Pain Drugs Product Offered

Table 151. Johnson & Johnson Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 152. Johnson & Johnson Main Business

Table 153. Johnson & Johnson Latest Developments

Table 154. GlaxoSmithKline Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. GlaxoSmithKline Osteoarthritis Pain Drugs Product Offered

Table 156. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 157. GlaxoSmithKline Main Business

Table 158. GlaxoSmithKline Latest Developments

Table 159. Mylan Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Mylan Osteoarthritis Pain Drugs Product Offered

Table 161. Mylan Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 162. Mylan Main Business

Table 163. Mylan Latest Developments

Table 164. Lilly Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Lilly Osteoarthritis Pain Drugs Product Offered

Table 166. Lilly Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 167. Lilly Main Business

Table 168. Lilly Latest Developments

Table 169. Abbott Laboratories Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. Abbott Laboratories Osteoarthritis Pain Drugs Product Offered

Table 171. Abbott Laboratories Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 172. Abbott Laboratories Main Business

Table 173. Abbott Laboratories Latest Developments

Table 174. Almatica Pharma Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 175. Almatica Pharma Osteoarthritis Pain Drugs Product Offered

Table 176. Almatica Pharma Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 177. Almatica Pharma Main Business

Table 178. Almatica Pharma Latest Developments

Table 179. TEVA Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 180. TEVA Osteoarthritis Pain Drugs Product Offered

Table 181. TEVA Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 182. TEVA Main Business

Table 183. TEVA Latest Developments

Table 184. Iroko Pharmaceuticals Basic Information, Osteoarthritis Pain Drugs Manufacturing Base, Sales Area and Its Competitors

Table 185. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Offered

Table 186. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (M Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 187. Iroko Pharmaceuticals Main Business

Table 188. Iroko Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Osteoarthritis Pain Drugs

Figure 2. Osteoarthritis Pain Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Osteoarthritis Pain Drugs Sales Growth Rate 2016-2026 (M Dose)

Figure 7. Global Osteoarthritis Pain Drugs Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Osteoarthritis Pain Drugs Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Oral

Figure 10. Product Picture of Injection

Figure 11. Product Picture of External

Figure 12. Global Osteoarthritis Pain Drugs Sales Market Share by Type in 2020

Figure 13. Global Osteoarthritis Pain Drugs Revenue Market Share by Type (2016-2021)

Figure 14. Osteoarthritis Pain Drugs Consumed in Medical Care

Figure 15. Global Osteoarthritis Pain Drugs Market: Medical Care (2016-2021) & (M Dose)

Figure 16. Osteoarthritis Pain Drugs Consumed in Personal Care

Figure 17. Global Osteoarthritis Pain Drugs Market: Personal Care (2016-2021) & (M Dose)

Figure 18. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2016-2021)

Figure 19. Global Osteoarthritis Pain Drugs Revenue Market Share by Application in 2020

Figure 20. Global Osteoarthritis Pain Drugs Revenue Market by Company in 2020 ($ Million)

Figure 21. Global Osteoarthritis Pain Drugs Revenue Market Share by Company in 2020

Figure 22. Global Osteoarthritis Pain Drugs Sales Market Share by Regions (2016-2021)

Figure 23. Global Osteoarthritis Pain Drugs Revenue Market Share by Region in 2020

Figure 24. Americas Osteoarthritis Pain Drugs Sales 2016-2021 (M Dose)

Figure 25. Americas Osteoarthritis Pain Drugs Revenue 2016-2021 ($ Millions)

Figure 26. APAC Osteoarthritis Pain Drugs Sales 2016-2021 (M Dose)

Figure 27. APAC Osteoarthritis Pain Drugs Revenue 2016-2021 ($ Millions)

Figure 28. Europe Osteoarthritis Pain Drugs Sales 2016-2021 (M Dose)

Figure 29. Europe Osteoarthritis Pain Drugs Revenue 2016-2021 ($ Millions)

Figure 30. Middle East & Africa Osteoarthritis Pain Drugs Sales 2016-2021 (M Dose)

Figure 31. Middle East & Africa Osteoarthritis Pain Drugs Revenue 2016-2021 ($ Millions)

Figure 32. Americas Osteoarthritis Pain Drugs Sales Market Share by Country in 2020

Figure 33. Americas Osteoarthritis Pain Drugs Revenue Market Share by Country in 2020

Figure 34. Americas Osteoarthritis Pain Drugs Sales Market Share by Type in 2020

Figure 35. Americas Osteoarthritis Pain Drugs Sales Market Share by Application in 2020

Figure 36. United States Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 37. Canada Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 38. Mexico Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 39. Brazil Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 40. APAC Osteoarthritis Pain Drugs Sales Market Share by Region in 2020

Figure 41. APAC Osteoarthritis Pain Drugs Revenue Market Share by Regions in 2020

Figure 42. APAC Osteoarthritis Pain Drugs Sales Market Share by Type in 2020

Figure 43. APAC Osteoarthritis Pain Drugs Sales Market Share by Application in 2020

Figure 44. China Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 45. Japan Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 46. Korea Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 47. Southeast Asia Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 48. India Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 49. Australia Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 50. Europe Osteoarthritis Pain Drugs Sales Market Share by Country in 2020

Figure 51. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country in 2020

Figure 52. Europe Osteoarthritis Pain Drugs Sales Market Share by Type in 2020

Figure 53. Europe Osteoarthritis Pain Drugs Sales Market Share by Application in 2020

Figure 54. Germany Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 55. France Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 56. UK Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 57. Italy Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 58. Russia Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 59. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Country in 2020

Figure 60. Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Country in 2020

Figure 61. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Type in 2020

Figure 62. Middle East & Africa Osteoarthritis Pain Drugs Sales Market Share by Application in 2020

Figure 63. Egypt Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 64. South Africa Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 65. Israel Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 66. Turkey Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 67. GCC Country Osteoarthritis Pain Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles